Alvarado, Dindo L.
HRN: 18-01-71 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/11/2024
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
05/11/2024
05/18/2024
IV
500mg
Q8H
TBI Moderate Sec To VA
Waiting Final Action
Indication: Empiric Type of Infection: Central Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes